| IHA | idiopathic hyperaldosteronism; indirect hemagglutination; indirect hemagglutination antibody |
|---|---|
| HI antibody | Hemagglutination Inhibiting antibody; 혈구 응집 억제 항체 |
| HI Method | Hemagglutination Inhibiting Method; 혈구 응집 억제법 |
| MHA-TP | Micro-Hemagglutination Assay for antibodies to Treponema Pallidum |
| CCH | C-cell hyperplasia; chronic chloride hemagglutination; chronic cholestatic hepatitis |
| HIT | Hemagglutination inhibition test |
|---|---|
| IAHA | Immune adherence hemagglutination |
| IHA | Indirect Hemagglutination assay |
| PHA | Passive hemagglutination assays |
| hemagglutination | <haematology> Agglutination of red blood cells, often used to test for the presence of antibodies directed against red cell surface antigens or carbohydrate binding proteins or viruses in a solution. Requires that the agglutinin has at least two binding sites. (18 Nov 1997) |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|